Metastatic Breast Cancer Clinical Trials

Phase 3 trials are for combination of gemcitabine and carboplatin in triple negative metastatic cancer patients.

Multicenter phase 2 trials are being conducted to determine the safety and efficacy of tamoxifen in combination with Ralimetinib for advanced metastatic cancer.

Related Journals of Metastatic Breast Cancer Clinical Trials

Cancer Research journal, Cancer Science & Therapy journal, Clinical Trials journal, Cancer Surgery, Clinical Breast Cancer, Journal of Clinical Oncology, Indian Journal of Pharmaceutical Sciences, Therapeutic Advances in Medical Oncology, British Journal of Cancer.